Last reviewed · How we verify

NCT07021287

Effect of Different Cold Therapy Programs in Patients Received Total Knee Arthroplasty Operation

Recruiting now NA Last updated 13 June 2025
What this trial tests

NA trial testing mixed ice and water, continuous ice application in Total Knee Arthroplasty in 260 participants. Currently enrolling.

Timeline
6 July 2024
Primary endpoint
1 April 2026
1 June 2026

Quick facts

Lead sponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposesupportive care
Enrollment260
Start date6 July 2024
Primary completion1 April 2026
Estimated completion1 June 2026
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Who can join

18 and older, any sex, with Total Knee Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study conducts clinical experiments on the form, temperature, frequency and other issues of cooling therapy, so as to provide scientific evidence for the practice of cooling therapy and improve the comfort and effect of cooling therapy, so as to achieve the goal of improving service and patient experience proposed by the National Health Commission.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Total Knee Arthroplasty

Currently open trials in the same condition.

Other The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07021287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing